Structural requirements of simple organic cations for recognition by multidrug-resistant cells

We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1992-11, Vol.52 (22), p.6385-6389
Hauptverfasser: DELLINGER, M, PRESSMAN, B. C, CALDERON-HIGGINSON, C, SAVARAJ, N, TAPIERO, H, KOLONIAS, D, LAMPIDIS, T. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6389
container_issue 22
container_start_page 6385
container_title Cancer research (Chicago, Ill.)
container_volume 52
creator DELLINGER, M
PRESSMAN, B. C
CALDERON-HIGGINSON, C
SAVARAJ, N
TAPIERO, H
KOLONIAS, D
LAMPIDIS, T. J
description We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73283248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73283248</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-404fd31dd8bbbd68f417ea419e266aa40564fe5df739f0770d1138539fed28813</originalsourceid><addsrcrecordid>eNo9kEtLAzEUhYMotVZ_gpCFuBtIJskkXUrxBQUX6tYhk0eNZJI2j0X_vVMcXF3OPR_nXO4ZWGJGRMMpZedgiRASDaO8vQRXOf9MkmHEFmCBCROUkCX4ei-pqlKT9DCZQ3XJjCaUDKOF2Y17b2BMOxmcgkoWF0OGNqYJVXEX3GkBhyMcqy9Op7prkskuFxkKVMb7fA0urPTZ3MxzBT6fHj82L8327fl187BtvttuXRqKqNUEay2GYdCdsBRzIylem7brpKSIddQapi0na4s4RxpjItgkjG6FwGQF7v9y9ykeqsmlH10-XSCDiTX3nLSCtFRM4O0M1mE0ut8nN8p07OeHTP7d7MuspLdJBuXyP0Yppmjq_gUCrmvX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73283248</pqid></control><display><type>article</type><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</creator><creatorcontrib>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</creatorcontrib><description>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P &gt; -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths &gt; four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 1358433</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Antineoplastic agents ; ATP-Binding Cassette, Sub-Family B, Member 1 ; Biological and medical sciences ; Cations - pharmacology ; Cell Division - drug effects ; Chemical Phenomena ; Chemistry, Physical ; Drug Resistance - physiology ; General aspects ; Guanidine ; Guanidines - pharmacology ; Humans ; Medical sciences ; Membrane Glycoproteins - physiology ; Pharmacology. Drug treatments ; Pyridinium Compounds - pharmacology ; Structure-Activity Relationship ; Tumor Cells, Cultured - drug effects ; Verapamil - pharmacology</subject><ispartof>Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6385-6389</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4414011$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1358433$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DELLINGER, M</creatorcontrib><creatorcontrib>PRESSMAN, B. C</creatorcontrib><creatorcontrib>CALDERON-HIGGINSON, C</creatorcontrib><creatorcontrib>SAVARAJ, N</creatorcontrib><creatorcontrib>TAPIERO, H</creatorcontrib><creatorcontrib>KOLONIAS, D</creatorcontrib><creatorcontrib>LAMPIDIS, T. J</creatorcontrib><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P &gt; -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths &gt; four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>ATP-Binding Cassette, Sub-Family B, Member 1</subject><subject>Biological and medical sciences</subject><subject>Cations - pharmacology</subject><subject>Cell Division - drug effects</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Drug Resistance - physiology</subject><subject>General aspects</subject><subject>Guanidine</subject><subject>Guanidines - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridinium Compounds - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Verapamil - pharmacology</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLAzEUhYMotVZ_gpCFuBtIJskkXUrxBQUX6tYhk0eNZJI2j0X_vVMcXF3OPR_nXO4ZWGJGRMMpZedgiRASDaO8vQRXOf9MkmHEFmCBCROUkCX4ei-pqlKT9DCZQ3XJjCaUDKOF2Y17b2BMOxmcgkoWF0OGNqYJVXEX3GkBhyMcqy9Op7prkskuFxkKVMb7fA0urPTZ3MxzBT6fHj82L8327fl187BtvttuXRqKqNUEay2GYdCdsBRzIylem7brpKSIddQapi0na4s4RxpjItgkjG6FwGQF7v9y9ykeqsmlH10-XSCDiTX3nLSCtFRM4O0M1mE0ut8nN8p07OeHTP7d7MuspLdJBuXyP0Yppmjq_gUCrmvX</recordid><startdate>19921115</startdate><enddate>19921115</enddate><creator>DELLINGER, M</creator><creator>PRESSMAN, B. C</creator><creator>CALDERON-HIGGINSON, C</creator><creator>SAVARAJ, N</creator><creator>TAPIERO, H</creator><creator>KOLONIAS, D</creator><creator>LAMPIDIS, T. J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19921115</creationdate><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><author>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-404fd31dd8bbbd68f417ea419e266aa40564fe5df739f0770d1138539fed28813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>ATP-Binding Cassette, Sub-Family B, Member 1</topic><topic>Biological and medical sciences</topic><topic>Cations - pharmacology</topic><topic>Cell Division - drug effects</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Drug Resistance - physiology</topic><topic>General aspects</topic><topic>Guanidine</topic><topic>Guanidines - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridinium Compounds - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Verapamil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DELLINGER, M</creatorcontrib><creatorcontrib>PRESSMAN, B. C</creatorcontrib><creatorcontrib>CALDERON-HIGGINSON, C</creatorcontrib><creatorcontrib>SAVARAJ, N</creatorcontrib><creatorcontrib>TAPIERO, H</creatorcontrib><creatorcontrib>KOLONIAS, D</creatorcontrib><creatorcontrib>LAMPIDIS, T. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DELLINGER, M</au><au>PRESSMAN, B. C</au><au>CALDERON-HIGGINSON, C</au><au>SAVARAJ, N</au><au>TAPIERO, H</au><au>KOLONIAS, D</au><au>LAMPIDIS, T. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1992-11-15</date><risdate>1992</risdate><volume>52</volume><issue>22</issue><spage>6385</spage><epage>6389</epage><pages>6385-6389</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P &gt; -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths &gt; four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>1358433</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6385-6389
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_73283248
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
subjects Animals
Antineoplastic agents
ATP-Binding Cassette, Sub-Family B, Member 1
Biological and medical sciences
Cations - pharmacology
Cell Division - drug effects
Chemical Phenomena
Chemistry, Physical
Drug Resistance - physiology
General aspects
Guanidine
Guanidines - pharmacology
Humans
Medical sciences
Membrane Glycoproteins - physiology
Pharmacology. Drug treatments
Pyridinium Compounds - pharmacology
Structure-Activity Relationship
Tumor Cells, Cultured - drug effects
Verapamil - pharmacology
title Structural requirements of simple organic cations for recognition by multidrug-resistant cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T01%3A36%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20requirements%20of%20simple%20organic%20cations%20for%20recognition%20by%20multidrug-resistant%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=DELLINGER,%20M&rft.date=1992-11-15&rft.volume=52&rft.issue=22&rft.spage=6385&rft.epage=6389&rft.pages=6385-6389&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73283248%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73283248&rft_id=info:pmid/1358433&rfr_iscdi=true